PATENT CLAIM ANALYSIS

Application Number: 16204748
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["546", "290000"]

Abstract:
The present invention includes novel substituted 1-hydroxy-pyridin-2(1H)-ones, which can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention inhibit HBV RNAse H activity.

Claim (Index 2):
The compound of  claim 1 , wherein each occurrence of alkyl or cycloalkyl is independently optionally substituted with at least one substituent selected from the group consisting of C 1 -C 6  alkyl, halo, keto (C\u2550O), \u2014OR, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted heterocyclyl, \u2014N(R)(R), \u2014N(R)\u2014(C\u2550O)R, \u2014C(\u2550O)R, \u2014C(\u2550O)(optionally substituted phenyl), \u2014C(\u2550O)(optionally substituted heteroaryl), \u2014C(\u2550O)N(R)(R), \u2014C(\u2550O)(CH 2 ) 0-3 OR, \u2014S(\u2550O) 2 R, and \u2014SO 2 N(R)(R), wherein each occurrence of R is independently selected from the group consisting of H, C 1 -C 6  alkyl, and C 3 -C 8  cycloalkyl.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.17073
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16204584', '13796437', '16477533', '15512494', '16070014']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7794818204781907
- 35 USC 102 Novelty (BERT): 0.5155477476712642
- Combined Prediction Score: 0.7530884131974981
- Mean Citation Score: 280.055348
- Max Citation Score: 325.22662
- Similarity Product: 311.31740494972706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test